BMY vs HLIO · P/E 17, rev $24.46B vs P/E 47, rev $460.3M
Bristol-Myers Squibb Company (BMY) versus Helios Technologies Inc (HLIO) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Helios Technologies Inc (HLIO) is a specialty industrial machinery company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported HLIO revenue for 2026-07-04 was $460.3M. Net income was $41.6M. HLIO currently screens at market cap $2.84B and trailing P/E 47.2.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. HLIO currently screens at market cap $2.84B and trailing P/E 47.2.
Not investment advice. Open the BMY and HLIO stock pages for the full models.
Not investment advice.